TR201902023T4 - Smac mimetikleri olarak 6-alkinil-piridin türevleri. - Google Patents
Smac mimetikleri olarak 6-alkinil-piridin türevleri. Download PDFInfo
- Publication number
- TR201902023T4 TR201902023T4 TR2019/02023T TR201902023T TR201902023T4 TR 201902023 T4 TR201902023 T4 TR 201902023T4 TR 2019/02023 T TR2019/02023 T TR 2019/02023T TR 201902023 T TR201902023 T TR 201902023T TR 201902023 T4 TR201902023 T4 TR 201902023T4
- Authority
- TR
- Turkey
- Prior art keywords
- alkynyl
- smac mimetics
- pyridine derivatives
- smac
- mimetics
- Prior art date
Links
- 229940075439 smac mimetic Drugs 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Bu buluş, genel formül (I) ile gösterilen 6-alkinil-piridin ile, bunların SMAC mimetikleri olarak kullanımları ile, bunları içeren farmasötik bileşimler ile, ve bunların, kanser gibi, aşırı veya anormal hücre proliferasyonu ile karakterize edilen hastalıkların önlenmesi ve/veya tedavisi için ilaç olarak kullanımı ile ilgilidir. R1 ila R4 arasındaki gruplar, istemlerde ve açıklamada verilen anlamlara sahiptir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14180554 | 2014-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201902023T4 true TR201902023T4 (tr) | 2019-03-21 |
Family
ID=51300621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/02023T TR201902023T4 (tr) | 2014-08-11 | 2015-08-10 | Smac mimetikleri olarak 6-alkinil-piridin türevleri. |
Country Status (34)
| Country | Link |
|---|---|
| US (4) | US9481673B2 (tr) |
| EP (1) | EP3180339B1 (tr) |
| JP (1) | JP6250226B2 (tr) |
| KR (1) | KR102445744B1 (tr) |
| CN (2) | CN106573930B (tr) |
| AP (1) | AP2017009718A0 (tr) |
| AR (1) | AR101479A1 (tr) |
| AU (1) | AU2015303308B2 (tr) |
| BR (1) | BR112017002498B1 (tr) |
| CA (1) | CA2956123C (tr) |
| CL (1) | CL2017000326A1 (tr) |
| CO (1) | CO2017001226A2 (tr) |
| CY (1) | CY1121273T1 (tr) |
| DK (1) | DK3180339T3 (tr) |
| EA (1) | EA031424B1 (tr) |
| ES (1) | ES2711763T3 (tr) |
| HR (1) | HRP20190336T1 (tr) |
| HU (1) | HUE043915T2 (tr) |
| IL (1) | IL249844B (tr) |
| LT (1) | LT3180339T (tr) |
| ME (1) | ME03303B (tr) |
| MX (1) | MX2017001835A (tr) |
| NZ (1) | NZ728073A (tr) |
| PE (1) | PE20170193A1 (tr) |
| PH (1) | PH12017500231A1 (tr) |
| PL (1) | PL3180339T3 (tr) |
| PT (1) | PT3180339T (tr) |
| RS (1) | RS58355B1 (tr) |
| SG (1) | SG11201700999YA (tr) |
| SI (1) | SI3180339T1 (tr) |
| TR (1) | TR201902023T4 (tr) |
| TW (1) | TWI723959B (tr) |
| UA (1) | UA118887C2 (tr) |
| WO (1) | WO2016023858A1 (tr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR101479A1 (es) * | 2014-08-11 | 2016-12-21 | Boehringer Ingelheim Int | Derivados de 6-alquinil-piridina |
| KR102392581B1 (ko) * | 2016-05-19 | 2022-04-28 | 베링거 인겔하임 인터내셔날 게엠베하 | 6-알키닐-피리딘 유도체의 제조 방법 |
| CN110475567A (zh) * | 2017-03-31 | 2019-11-19 | 勃林格殷格翰国际有限公司 | 抗癌组合疗法 |
| EP3886842A1 (en) | 2018-11-26 | 2021-10-06 | Debiopharm International SA | Combination treatment of hiv infections |
| TW202043466A (zh) | 2019-01-25 | 2020-12-01 | 德商百靈佳殷格翰國際股份有限公司 | 編碼ccl21之重組棒狀病毒 |
| MX2022003628A (es) | 2019-09-25 | 2022-07-21 | Debiopharm Int Sa | Regímenes de dosificación para el tratamiento de pacientes con carcinoma de células escamosas avanzado localmente. |
| CR20220606A (es) | 2020-06-03 | 2023-01-23 | Boehringer Ingelheim Int | Rhabdovirus recombinante que codifica una proteína de fusión fc de dominio extracelular cd80 |
| WO2024175554A1 (en) | 2023-02-21 | 2024-08-29 | Institut Curie | Trail agonists for use in the treatment of cancer in patients having an activating alteration of fgfr3 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060234360A1 (en) * | 2005-04-13 | 2006-10-19 | Paola Branduardi | Ascorbic acid production from D-glucose in yeast |
| MX2007015419A (es) | 2005-06-08 | 2008-02-21 | Novartis Ag | Compuestos organicos. |
| WO2007101347A1 (en) | 2006-03-07 | 2007-09-13 | Aegera Therapeutics Inc. | Bir domain binding compounds |
| CN101595093A (zh) * | 2006-12-07 | 2009-12-02 | 诺瓦提斯公司 | 有机化合物 |
| US8859541B2 (en) * | 2012-02-27 | 2014-10-14 | Boehringer Ingelheim International Gmbh | 6-alkynylpyridines |
| US9278978B2 (en) | 2013-08-23 | 2016-03-08 | Boehringer Ingelheim International Gmbh | 6-Alkynyl Pyridine |
| US9249151B2 (en) | 2013-08-23 | 2016-02-02 | Boehringer Ingelheim International Gmbh | Bis-amido pyridines |
| AR101479A1 (es) | 2014-08-11 | 2016-12-21 | Boehringer Ingelheim Int | Derivados de 6-alquinil-piridina |
-
2015
- 2015-08-07 AR ARP150102551A patent/AR101479A1/es unknown
- 2015-08-10 TR TR2019/02023T patent/TR201902023T4/tr unknown
- 2015-08-10 CN CN201580039248.1A patent/CN106573930B/zh active Active
- 2015-08-10 ME MEP-2019-29A patent/ME03303B/me unknown
- 2015-08-10 SG SG11201700999YA patent/SG11201700999YA/en unknown
- 2015-08-10 TW TW104125989A patent/TWI723959B/zh active
- 2015-08-10 RS RS20190219A patent/RS58355B1/sr unknown
- 2015-08-10 DK DK15747820.7T patent/DK3180339T3/en active
- 2015-08-10 LT LTEP15747820.7T patent/LT3180339T/lt unknown
- 2015-08-10 CN CN201911357061.2A patent/CN111440164B/zh active Active
- 2015-08-10 CA CA2956123A patent/CA2956123C/en active Active
- 2015-08-10 BR BR112017002498-5A patent/BR112017002498B1/pt active IP Right Grant
- 2015-08-10 WO PCT/EP2015/068349 patent/WO2016023858A1/en active Application Filing
- 2015-08-10 US US14/821,870 patent/US9481673B2/en active Active
- 2015-08-10 MX MX2017001835A patent/MX2017001835A/es active IP Right Grant
- 2015-08-10 AP AP2017009718A patent/AP2017009718A0/en unknown
- 2015-08-10 PL PL15747820T patent/PL3180339T3/pl unknown
- 2015-08-10 HU HUE15747820A patent/HUE043915T2/hu unknown
- 2015-08-10 ES ES15747820T patent/ES2711763T3/es active Active
- 2015-08-10 JP JP2017507775A patent/JP6250226B2/ja active Active
- 2015-08-10 SI SI201530611T patent/SI3180339T1/sl unknown
- 2015-08-10 AU AU2015303308A patent/AU2015303308B2/en active Active
- 2015-08-10 PT PT15747820T patent/PT3180339T/pt unknown
- 2015-08-10 EA EA201790349A patent/EA031424B1/ru not_active IP Right Cessation
- 2015-08-10 EP EP15747820.7A patent/EP3180339B1/en active Active
- 2015-08-10 KR KR1020177005822A patent/KR102445744B1/ko active IP Right Grant
- 2015-08-10 PE PE2017000209A patent/PE20170193A1/es unknown
- 2015-08-10 NZ NZ728073A patent/NZ728073A/en unknown
- 2015-10-08 UA UAA201702213A patent/UA118887C2/uk unknown
-
2016
- 2016-10-03 US US15/283,494 patent/US9801871B2/en active Active
- 2016-12-29 IL IL249844A patent/IL249844B/en active IP Right Grant
-
2017
- 2017-02-08 CO CONC2017/0001226A patent/CO2017001226A2/es unknown
- 2017-02-08 PH PH12017500231A patent/PH12017500231A1/en unknown
- 2017-02-08 CL CL2017000326A patent/CL2017000326A1/es unknown
- 2017-09-26 US US15/715,351 patent/US10413536B2/en active Active
-
2019
- 2019-02-19 CY CY20191100213T patent/CY1121273T1/el unknown
- 2019-02-20 HR HRP20190336TT patent/HRP20190336T1/hr unknown
- 2019-08-02 US US16/530,084 patent/US20190358218A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118859T1 (el) | 6-αλκινυλο-πυριδινες ως μιμητες smac | |
| TR201902023T4 (tr) | Smac mimetikleri olarak 6-alkinil-piridin türevleri. | |
| CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
| CY1120935T1 (el) | Νεες συνθεσεις, χρησεις και μεθοδοι για την παρασκευη αυτων | |
| TR201819138T4 (tr) | FGFR Kinaz Modülatörleri Olarak Faydalı Kinoksalin Türevleri | |
| CL2015002767A1 (es) | Compuestos terapéuticos y composiciones | |
| PH12015501385A1 (en) | Autotaxin inhibitors | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| UY35711A (es) | Bis-amidopiridinas como moduladores de la actividad de iap y sus usos como miméticos de smac | |
| UY35710A (es) | 6-alquinilpiridinas como moduladores de la actividad de iap y sus usos como miméticos de smac | |
| MX2017007377A (es) | Compuestos organicos. | |
| TR201900659T4 (tr) | Mineralokortikoid reseptör modülatörleri olarak benzoksazinon amidleri. | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| DOP2017000058A (es) | Derivados de tetrahidroquinolina como inhibidores del bromodominio | |
| TR201819805T4 (tr) | Flavaglin türevleri̇. | |
| MX371158B (es) | Compuestos inhibidores de pde2. | |
| DOP2016000325A (es) | Compuestos, composición farmacéutica y su uso en el tratamiento de enfermedades neurodegenerativas | |
| UY34459A (es) | Compuestos para tratamiento y prevención de adherencias, composiciones farmacéuticas relacionadas c on los compuestos y métodos para la prevención y tratamiento de adherencias |